Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3041965

O=C(O)C(F)(F)F.c1ccc(CCCNCc2ccc(-c3ccc4[nH]cnc4c3)cc2)cc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.47
HTR5A P47898 10/20 0.46
HTR1A P08908 3/20 0.44
DRD2 P14416 3/20 0.44
DRD4 P21917 3/20 0.44
HTR1D P28221 3/20 0.44
HTR1B P28222 3/20 0.44
HTR2A P28223 3/20 0.44
HTR2C P28335 3/20 0.44
HTR7 P34969 3/20 0.44
ADRA1B P35368 3/20 0.44
DRD3 P35462 3/20 0.44
HTR2B P41595 3/20 0.44
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3051554 0.87 KDM4E (0.47) HDAC1HTR5AHTR1ADRD2DRD4
Trifluoroacetic Acid SCHEMBL3051308 0.86 HTR5A (0.44) HDAC1HTR5AHTR1ADRD2DRD4
Trifluoroacetic Acid SCHEMBL3051304 0.86 MEN1 (0.44) HTR5AHTR1ADRD2DRD4HTR1D
Trifluoroacetic Acid SCHEMBL3034897 0.85 KDM4E (0.48) HTR5AHTR1ADRD2DRD4HTR1D
Trifluoroacetic Acid SCHEMBL3037461 0.84 S1PR2 (0.38) HTR5AHTR1ADRD2DRD4HTR1D
Trifluoroacetic Acid SCHEMBL3038466 0.84 EPHB4 (0.39) HDAC1HTR5AHTR1ADRD2DRD4
Trifluoroacetic Acid SCHEMBL3047191 0.83 HDAC1 (0.45) HDAC1HTR5AHDAC3HDAC2
Trifluoroacetic Acid SCHEMBL3044503 0.83 HTR5A (0.44) HTR5AHTR1ADRD2DRD4HTR1D
SCHEMBL13136970 0.82 QPCT (0.52) HDAC1BCHESIGMAR1
Trifluoroacetic Acid SCHEMBL1872849 0.82 OPRM1 (0.53) HTR5ABCHEOPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS OPRL1, OPRM1, OPRK1 HDAC1 2221/4885HTR5A 190/4885HTR1A 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.